NCT00002635View on ClinicalTrials.gov

Aminocamptothecin in Treating Patients With T-cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 31, 1995

Primary Completion Date

April 30, 2000

Study Completion Date

April 30, 2000

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

aminocamptothecin

Trial Locations (3)

60611

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

06520-8028

Yale Comprehensive Cancer Center, New Haven

02111

New England Medical Center Hospital, Boston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Yale University

OTHER